Eric Swayze - 28 Feb 2025 Form 4 Insider Report for IONIS PHARMACEUTICALS INC (IONS)

Role
EVP Research
Signature
By: Patrick R. O'Neil, attorney-in-fact For: Eric Swayze
Issuer symbol
IONS
Transactions as of
28 Feb 2025
Net transactions value
+$11,708
Form type
4
Filing time
04 Mar 2025, 17:17:02 UTC
Previous filing
03 Feb 2025
Next filing
04 Sep 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IONS Common Stock Other $11,708 +415 +0.86% $28.21 48,432 28 Feb 2025 Direct F1
holding IONS Common Stock 184 28 Feb 2025 by Son
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reporting shares purchased under the Ionis Pharmaceuticals, Inc. Amended and Restated 2000 Employee Stock Purchase Plan on February 28,2025. These shares may not be sold until August 28, 2025.